RECENT NEWS

Axol Bioscience has expanded its service offering with the introduction of multi-electrode array (MEA) screening for human induced pluripotent stem cell (hiPSC)-derived cells.

Menarini Diagnostics is expanding its comprehensive cellular pathology portfolio with ARKIVE BC and ARKIVE SL solutions for automated archiving and retrieval of histological blocks and slides.

Torrey Pines Scientific has launched its EchoTherm RIC40 Peltier-driven, compact chilling/heating dry baths with temperatures selectable from 0ºC to 100ºC, which are designed for use with robotic systems, controlled via the RS232 I/O port.

Kidney Biomarkers: Clinical Aspects and Laboratory Determination is a new textbook, edited by Seema S Ahuja and Brian Castillo, which covers currently used biomarkers and markers that are in development.

This year’s virtual.MEDICA presents specialist topics in laboratory medicine and reflects the significance of this sector in the fight against the coronavirus pandemic.

The latest data on non-tuberculous mycobacteria (NTM) was presented at this year’s virtual European Respiratory Society Congress, during which some 33,000 delegates logged on to the Congress platform.

The QuickGene series of instruments and kits from Alpha Laboratories provides a novel, innovate method for DNA and RNA extraction from a range of sample types, all without the need for centrifugation.

Congratulations are due to Alan Wainwright, Executive Head of Education at the Institute of Biomedical Science, who has been elected President of the International Federation of Biomedical Laboratory Science.

In the June issue, Tony Rhodes looked at where we have come from with respect to molecular techniques in histopathology. Here, he looks forward, in a piece the title of which sounds slightly Trecky! “It’s histology Jim, but not as we know it”.

HORIBA UK, Medical has received recognition for a new partnership with Britannia Pharmaceuticals and Northumberland Tyne & Wear Mental Health Trust (NTW) for community-based near-patient testing for treatment-resistant schizophrenia patients.

The National Institute for Health and Care Excellence has published guidance on high-sensitivity troponin tests for early rule out of non-ST-segment elevation myocardial infarction (NSTEMI), recommending assays such as Beckman Coulter’s Access hsTnI.

SYNLAB UK & Ireland has announced that it will become Guy’s and St Thomas’ NHS Foundation Trust and King’s College Hospital NHS Foundation Trust’s new pathology partner, transforming services across south-east London over the next 15 years.

Endotoxin testing is a vital assay for all injectable or implantable products. PYROSTAR, now available from Alpha Laboratories, enables in-house endotoxin testing, providing full control over one of the most important aspects of quality control.

The British In Vitro Diagnostics Association (BIVDA) has welcomed publication of ‘Diagnostics: Recovery and Renewal’, a major review of diagnostic services by NHS England.

Xyall, an innovator in molecular pathology, has entered a strategic partnership with Motic, a world leader in microscopy and digital pathology systems, to develop an automated tumour tissue dissection solution for molecular pathology laboratories.

Mast has been awarded the Public Health England (PHE) tender for the exclusive supply of antibiotic susceptibility (AST) and AMR discs. Mast is delighted with this decision and looks forward to strengthening its existing relationship with PHE.

Publication of the October issue of Pathology in Practice is imminent, offering its usual mixture of news, professional, commercial and scientific features.

PCR Biosystems has expanded its range of molecular biology kits by introducing the NGSBIO Library Quant Kit for Illumina, which contains everything necessary for quantification of DNA libraries prior to NGS with Illumina platforms.

The British In Vitro Diagnostics Association (BIVDA) has commented on a recent NHS Confederation report, which focuses on the policy levers needed to put the NHS back onto a secure footing in the months ahead.

Diaceutics has announced three new partnerships on its DXRX platform, as it continues on its mission to get every patient the treatment they deserve.